Speaker v. U.S. Department of Health & Human Services Centers for Disease Control & Prevention

623 F.3d 1371, 77 Fed. R. Serv. 3d 1059, 2010 U.S. App. LEXIS 22422, 2010 WL 4136634
CourtCourt of Appeals for the Eleventh Circuit
DecidedOctober 22, 2010
Docket09-16154
StatusPublished
Cited by313 cases

This text of 623 F.3d 1371 (Speaker v. U.S. Department of Health & Human Services Centers for Disease Control & Prevention) is published on Counsel Stack Legal Research, covering Court of Appeals for the Eleventh Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Speaker v. U.S. Department of Health & Human Services Centers for Disease Control & Prevention, 623 F.3d 1371, 77 Fed. R. Serv. 3d 1059, 2010 U.S. App. LEXIS 22422, 2010 WL 4136634 (11th Cir. 2010).

Opinion

HULL, Circuit Judge:

Plaintiff Andrew Harley Speaker (“Speaker”) sued the Defendant United States Department of Health and Human Services Centers for Disease Control and Prevention (“CDC”) for violating the Privacy Act, 5 U.S.C. § 552a, by disclosing his identity and confidential medical information relating to the treatment of his tuberculosis. Plaintiff Speaker appeals the district court’s grant of Defendant CDC’s motion to dismiss for failure to state a claim under Federal Rule of Civil Procedure 12(b)(6). After review and oral argument, we reverse.

I. BACKGROUND

A. Speaker’s Amended, Complaint

In this Rule 12(b)(6) context, we start by outlining the allegations in Plaintiff Speaker’s Amended Complaint, which seeks to recover damages under the Privacy Act, 5 U.S.C. § 552a.

Speaker first tested positive for tuberculosis in March 2007. In April 2007, after undergoing tests and treatments, Speaker received a preliminary susceptibility test result suggesting an elevated diagnosis of multidrug-resistant tuberculosis (“MDR-TB”).

During the course of Speaker’s treatment, several CDC employees became aware of his intention to travel to Europe in May 2007 for his wedding ceremony and honeymoon. Speaker cites e-mail records of CDC officials acknowledging the upcoming trip as evidence that the CDC was planning treatment options around these *1375 travel plans. CDC officials were also aware that Speaker’s doctor at the Fulton County Health Department Tuberculosis Program was advising further care at the National Jewish Medical and Research Center in Denver upon Speaker’s return. This contradicted later public statements by the CDC that it had no knowledge of Speaker’s travel plans.

In the days leading up to his departure, Speaker claims health officials repeatedly gave assurances that he was not contagious or a threat to anyone, and that no public health official advised him against traveling abroad. On May 12, 2007, Speaker departed for Europe.

Soon afterwards, the CDC lab received test results indicating increased resistance to drug treatments. The CDC then reclassified Speaker’s tuberculosis as extensively drug-resistant tuberculosis (“XDR-TB”), a more virulent strain. On May 22, Speaker was contacted in Europe by Dr. Bob Cooksey, a microbiologist in the CDC’s Division of Tuberculosis Elimination, 1 about a change in test results. Speaker immediately contacted Dr. David Kim, a CDC employee, who informed him that the CDC had elevated his tuberculosis diagnosis to XDR-TB. Dr. Kim allegedly informed him that, while his treatment options would change, he remained noncontagious.

Nevertheless, the CDC forbade Speaker from flying on a commercial airliner. Dr. Kim notified Speaker that the CDC was making arrangements to fly him back to the United States. The next day, however, Dr. Kim informed Speaker that the CDC did not have money in its budget to pay for the flight. Dr. Kim gave Speaker two options: he could charter a private flight if he wished to return to the United States for treatment, or he could check into an Italian hospital the next day.

Although he had been told by his doctor that the National Jewish Medical and Research Center in Denver presented his best treatment option, Speaker could not afford a chartered flight to the United States. Faced with the prospect of indefinite detainment in Italy, and relying upon the statements of health officials that he was not contagious, Speaker elected to disregard the CDC’s travel instructions and booked a flight to Montreal on a commercial airliner. Speaker then crossed the border by car into the United States, notifying the CDC of his whereabouts. The CDC directed Speaker to check himself into Bellevue Hospital in New York City, which Speaker did. At Bellevue, Speaker was served with a federal quarantine order, the first imposed on a United States citizen since 1963. Speaker subsequently received treatment at Grady Memorial Hospital in Atlanta and the National Jewish Medical and Research Center in Denver.

Upon being hospitalized, Speaker alleges that “the CDC caused personally identifiable information about [him] to be improperly disclosed without his consent to law enforcement officials, the news media, and the general public as a result of the deliberate actions of the CDC and its employees or agents.” Am. Compl. ¶ 82. Speaker accuses the CDC of causing the following disclosures of his “personally identifiable information”:

a) Public disclosures to the international news media during press conferences and interviews held on or about May 29 and 30, June 1, and July 3 and 11, 2007;
b) Upon information and belief, other disclosures by CDC agents or em *1376 ployees to members of the media during the time frame of said public press conferences and interviews, including but not limited to information that enabled the media to ascertain Mr. Speaker’s identity and whereabouts on or about May 29, 2007 and to publish his name on and after May 31, 2007;
c) Upon information and belief, disclosure of Mr. Speaker’s identity to law enforcement officers who in turn leaked his identity to the Associated Press between May 29 and May 31, 2007;
d) Upon information and belief, confirmation of Mr. Speaker’s identity to the Associated Press between May 29 and 31, 2007;
e) Upon information and belief, other disclosures made as part of a media campaign directed toward Mr. Speaker and his disease that will be identified through discovery and proven at trial.

Id. ¶ 83.

Although Speaker’s Amended Complaint alleges the CDC “caused” disclosures, Speaker elsewhere in the Amended Complaint refers to the CDC “making the aforementioned disclosures about Mr. Speaker.” Id. ¶ 84 (emphasis added). Other examples make clear that Speaker alleges direct disclosures of his identity by the CDC. See, e.g., id. ¶ 1 (referring to the CDC’s “intentional, unauthorized disclosure of Plaintiffs confidential medical history”); id. ¶ 69 n. 2 (referring to “the CDC’s unlawful disclosure of Mr. Speaker’s identity and private health information to the world media”); id. ¶ 103 (referring to “the CDC’s highly publicized release of Mr. Speaker’s private information”); id. ¶ 106 (stating that “[t]he aforementioned disclosures by the Defendant CDC about Plaintiff Andrew Speaker and his status as a tuberculosis patient resulted in the release of private identifiable information”); id. ¶ 108 (referring to “identifiable private information that the Defendant released about Mr. Speaker, including but not limited to his identity, his occupation, his city of residence, his wedding travel plans, his medical history, and his present medical status”);

Free access — add to your briefcase to read the full text and ask questions with AI

Related

MERCER v. YOUGHN
M.D. Georgia, 2025
LLOYD-ADAMS v. KELSCH
M.D. Georgia, 2025
Otoh v. Barr
N.D. Georgia, 2020
Pappalardo v. Stevins
Federal Circuit, 2018
BTG Patent Holdings, LLC v. Bag2Go, GmbH
193 F. Supp. 3d 1310 (S.D. Florida, 2016)
Robert G. Dello Russo v. Fifth Third Bank
634 F. App'x 774 (Eleventh Circuit, 2015)
Clayton Elliott v. Wells Fargo Bank, N.A.
633 F. App'x 917 (Eleventh Circuit, 2015)
Burns v. City of Alexander City
110 F. Supp. 3d 1237 (M.D. Alabama, 2015)
Strawser v. Strange
100 F. Supp. 3d 1276 (S.D. Alabama, 2015)
Carlos Urquilla-Diaz v. Kaplan University
780 F.3d 1039 (Eleventh Circuit, 2015)

Cite This Page — Counsel Stack

Bluebook (online)
623 F.3d 1371, 77 Fed. R. Serv. 3d 1059, 2010 U.S. App. LEXIS 22422, 2010 WL 4136634, Counsel Stack Legal Research, https://law.counselstack.com/opinion/speaker-v-us-department-of-health-human-services-centers-for-disease-ca11-2010.